Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Rang in Aktien #18868
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Aktienkurs
$2.51
Marktkapitalisierung
$183.34M
Veränderung (1 Tag)
0.90%
Veränderung (1 Jahr)
91.17%
Land
TW
Handel Steminent Biotherapeutics Inc. (7729)

Kategorie

Kursverlauf für Steminent Biotherapeutics Inc. (7729)
Höchster Schlusskurs: $2.51 am 2026-08-01

Niedrigster Schlusskurs: $0.98 am 2024-03-01
Kursverlauf der Aktie von Steminent Biotherapeutics Inc. von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 41.30%
2025 126.05%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$549.31 41.87%
US
$1.05K 47.91%
NL
$147.07 494.70%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH